William Blair & Company
CVET

William Blair & Company’s Covetrus, Inc. Common Stock CVET Stock Holding History

William Blair & Company’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,333
Closed -$206K – 2033
2021
Q4 		$206K Sell
10,333
-20,694
-67% -$390K ﹤0.01% 1564
2021
Q3 		$563K Sell
31,027
-616
-2% -$14.1K ﹤0.01% 1116
2021
Q2 		$854K Sell
31,643
-1,552
-5% -$43.4K ﹤0.01% 968
2021
Q1 		$995K Sell
33,195
-8,280
-20% -$282K ﹤0.01% 896
2020
Q4 		$1.19M Buy
41,475
+3,110
+8% +$83.9K ﹤0.01% 800
2020
Q3 		$936K Buy
38,365
+14,192
+59% +$306K ﹤0.01% 776
2020
Q2 		$432K Buy
24,173
+3,505
+17% +$46.1K ﹤0.01% 983
2020
Q1 		$168K Sell
20,668
-3,534
-15% -$40.4K ﹤0.01% 1208
2019
Q4 		$319K Sell
24,202
-5,927
-20% -$71.8K ﹤0.01% 1148
2019
Q3 		$358K Sell
30,129
-11,599
-28% -$215K ﹤0.01% 1058
2019
Q2 		$1.02M Sell
41,728
-38,095
-48% -$1.1M 0.01% 751
2019
Q1 		$2.54M Buy
+79,823
New +$2.83M 0.02% 500

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair & Company's CVET Position: Q1 2022 in Review

William Blair & Company sold out of Covetrus, Inc. Common Stock (CVET) in Q1 2022, closing a stake of 10,333 shares — an estimated $206K sold.

William Blair & Company first reported a position in CVET in Q1 2019 and held it in 12 quarters. The position peaked at $2.54M in Q1 2019. 257 funds tracked by Wall St. Rank hold CVET as of Q1 2022.

  • William Blair & Company reported no remaining Covetrus, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • William Blair & Company sold 10,333 Covetrus, Inc. Common Stock shares in Q1 2022, an estimated $206K.
  • William Blair & Company first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 12 quarters.
  • William Blair & Company's Covetrus, Inc. Common Stock position peaked at $2.54M in Q1 2019.
  • 257 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q1 2022.

Based on William Blair & Company's 13F filing for Q1 2022, filed 13 May 2022.